A detailed history of M&T Bank Corp transactions in Insmed Inc stock. As of the latest transaction made, M&T Bank Corp holds 391,075 shares of INSM stock, worth $75.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
391,075
Previous 4,094 9452.39%
Holding current value
$75.6 Million
Previous $589,000 12729.03%
% of portfolio
0.15%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 28, 2026

BUY
$147.28 - $194.39 $57 Million - $75.2 Million
386,981 Added 9452.39%
391,075 $75.6 Million
Q3 2025

Nov 14, 2025

BUY
$96.14 - $147.2 $164,399 - $251,711
1,710 Added 71.73%
4,094 $589,000
Q2 2025

Aug 13, 2025

SELL
$64.81 - $105.9 $58,912 - $96,263
-909 Reduced 27.6%
2,384 $239,000
Q1 2025

Apr 30, 2025

BUY
$65.25 - $83.83 $9,591 - $12,323
147 Added 4.67%
3,293 $251,000
Q4 2024

Feb 06, 2025

BUY
$66.29 - $76.63 $11,004 - $12,720
166 Added 5.57%
3,146 $217,000
Q3 2024

Nov 15, 2024

BUY
$62.0 - $79.01 $184,760 - $235,449
2,980 New
2,980 $217,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.